Human CD14 ELISA Kit

Contact us
Diaclone
Product Code: 850.780.048
Product Group: ELISA Kits
Supplier: Diaclone
CodeSizePrice
850.780.0481 x 48 Discovery (pre-coated)£227.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Human
Regulatory Status: RUO
Application: Enzyme-Linked Immunosorbent Assay (ELISA)

Further Information

Assay Range:
6.87-220 ng/ml
Cross reaction:
No cross reactivity with other human soluble molecules
Description:
Diaclone ELISA Kits include pre-coated strip plates biotinylated secondary antibody standards controls (where applicable) buffers streptavidin-HRP TMB stop reagents and a detailed procedure.
Detection Target:
CD14
Incubation:
3h45
Reactivity:
Human
Research Area:
Soluble Antigens
Sample Size:
100 µl
Sample Types:
Serum Plasma Cell culture supernatant
Sensitivity:
6 ng/ml
Specificity:
Recognizes both natural and recombinant human soluble CD14

References

  1. Rosado-S?nchez I. et al. Front Immunol. 2020; 11: 581307. . Increased Frequencies of Myeloid-Derived Suppressor Cells Precede Immunodiscordance in HIV-Infected Subjects. https://pubmed.ncbi.nlm.nih.gov/33240269/
  2. Negredo E. et al. PLoS One. 2020; 15(9): e0238575. . A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV. https://pubmed.ncbi.nlm.nih.gov/32941476/
  3. De Pablo-Bernal R. S. et al. J Gerontol A Biol Sci Med Sci.2015: glv121. Monocyte Phenotype and Polyfunctionality Are Associated With Elevated Soluble Inflammatory Markers Cytomegalovirus Infection and Functional and Cognitive Decline in Elderly Adults. https://www.ncbi.nlm.nih.gov/pubmed/26286603
  4. De Pablo-Bernal R. S. et al.The Journal of Infectious Disease2016;213(6): 999-1007. Phenotype and Polyfunctional Deregulation Involving Interleukin 6 (IL-6)- and IL-10-Producing Monocytes in HIV-Infected Patients Receiving Combination Antiretroviral Therapy Differ From Those in Healthy Older Individuals. https://www.ncbi.nlm.nih.gov/pubmed/26518043
  5. G?mez-Mora E. et al.PLoS One. 2017 Sep 21;12(9):e0184433.. Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery.. https://www.ncbi.nlm.nih.gov/pubmed/28934217
  6. Kasang C. et al. PLoS One2016?;11(1):e0146678 . Effects of Prednisolone on Disease Progression in Antiretroviral-Untreated HIV Infection: A 2-Year Randomized Double-Blind Placebo-Controlled Clinical Trial. https://www.ncbi.nlm.nih.gov/pubmed/26812052
  7. Kasang C. et al.BMC Infect Dis.2012; 12: 14. HIV patients treated with low-dose prednisolone exhibit lower immune activation than untreated patients. https://www.ncbi.nlm.nih.gov/pubmed/22264238
  8. Kurowski M. et al.Arch Med Sci. 2018 Jan;14(1):60-68.. Winter ambient training conditions are associated with increased bronchial hyperreactivity and with shifts in serum innate immunity proteins in young competitive speed skaters.. https://www.ncbi.nlm.nih.gov/pubmed/29379533
  9. Loo W. T. et al. J Transl Med.2012;10 Suppl 1: S9. Clinical application of human beta-defensin and CD14 gene polymorphism in evaluating the status of chronic inflammation.. https://www.ncbi.nlm.nih.gov/pubmed/23046822
  10. Magnusson M. K. et al.J Crohns Colitis2015;9(1): 56-65. Response to Infliximab Therapy in Ulcerative Colitis is Associated With Decreased Monocyte Activation Reduced CCL2 Expression and Downregulation of Tenascin C.. https://www.ncbi.nlm.nih.gov/pubmed/25518051
  11. Massanella M. et al.PLoS One2014; 9(12): e114142. Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals.. https://www.ncbi.nlm.nih.gov/pubmed/25462535
  12. M?ndez-LagaresG. et al.J. Antimicrob. Chemother. 2012; 10.1093/ jac/dkr594. Differential alterations of the CD4 and CD8 T cell subsets in HIV-infected patients on highly active antiretroviral therapy with low CD4 T cell restoration. https://www.ncbi.nlm.nih.gov/pubmed/22287235
  13. Picat M. Q. et al. PLoS One2017; 12(1): e0169164.. Integrative Analysis of Immunological Data to Explore Chronic Immune T-Cell Activation in Successfully Treated HIV Patients.. https://www.ncbi.nlm.nih.gov/pubmed/28046052
  14. PuertasM.C. et al.J Antimicrob Chemother. 2018 Jul 1;73(7):1940-1948. Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIs.. https://www.ncbi.nlm.nih.gov/pubmed/29635527
  15. Rotger M. et al. J Clin Invest.2011; 121(6): 2391-400. Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque.. https://www.ncbi.nlm.nih.gov/pubmed/21555857